AT&T Inc. T has added new healthcare benefits for its eligible wireless and fiber customers through a partnership with LifeMD, Inc. LFMD, offering complimentary access to virtual care and pharmacy services. The collaboration expands AT&T’s customer offerings by providing healthcare services alongside its wireless and fiber products.
Per the agreement, AT&T will provide more than 100 million eligible customers with a LifeMD membership worth $228 annually, waiving the regular $19 monthly fee. Customers can connect with healthcare providers for everyday health needs, obtain prescriptions and access pharmacy services, with many medications delivered directly through LifeMD’s pharmacy.
The company is offering the benefit through AT&T’s &More program, which provides members with savings and special deals. Customers must enroll to activate the complimentary membership and will pay only for the visits, prescriptions, or other services they use. The rollout will initially cover about 29 million AT&T customers in 11 states and is expected to expand nationwide in January 2027.
As demand for convenient telemedicine services continues to grow, the initiative supports AT&T’s efforts to broaden its customer benefits and strengthen engagement across its service ecosystem.
How Are Competitors Advancing in the Healthcare Sector?
AT&T faces stiff competition from Verizon Communications, Inc. VZ and T-Mobile US, Inc. TMUS. Verizon is enhancing its healthcare technology offerings with artificial intelligence (AI)-powered solutions for telehealth and connected care. Its AI Connect platform helps healthcare organizations manage secure, real-time data flows. Verizon provides network solutions to support connected medical devices and healthcare facilities.
T-Mobile is strengthening its healthcare offerings with 5G and wireless technologies that support telehealth and virtual care. The company provides private and hybrid 5G networks for healthcare organizations, helping connect facilities, applications and medical devices. T-Mobile’s solutions also support patient monitoring, connected hospital operations and secure digital healthcare services.
T’s Price Performance, Valuation & Estimates
AT&T shares have lost 8.9% over the past year against the industry’s growth of 94.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, AT&T trades at a forward price-to-sales ratio of 1.39, below the industry tally of 8.07.
Image Source: Zacks Investment Research
Earnings estimates for 2026 have increased 1.3% to $2.35 over the past 60 days, while the same for 2027 have risen 0.8% to $2.57.
Image Source: Zacks Investment Research
AT&T currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AT&T Inc. (T): Free Stock Analysis Report
Verizon Communications Inc. (VZ): Free Stock Analysis Report
T-Mobile US, Inc. (TMUS): Free Stock Analysis Report
LifeMD, Inc. (LFMD): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).